A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.
A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
Representatives from longtime supporter Balfour Beatty Construction visited the Medical Center recently to present an additional gift in support of the existing Balfour Beatty Research Fund for Personalized Cancer Medicine.
A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.